These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3871563)

  • 21. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phospholipidosis in rats treated with amiodarone: serum biochemistry and whole genome micro-array analysis supporting the lipid traffic jam hypothesis and the subsequent rise of the biomarker BMP.
    Mesens N; Desmidt M; Verheyen GR; Starckx S; Damsch S; De Vries R; Verhemeldonck M; Van Gompel J; Lampo A; Lammens L
    Toxicol Pathol; 2012 Apr; 40(3):491-503. PubMed ID: 22291062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Lung, mirror of iatrogenic diseases. Example of amiodarone].
    Michel FB; Godard P; Aubas P; Vic P
    Bull Acad Natl Med; 1986 Jan; 170(1):157-63. PubMed ID: 3527348
    [No Abstract]   [Full Text] [Related]  

  • 24. Electron microscopic demonstration of lysosomal inclusion bodies in lung, liver, lymph nodes, and blood leukocytes of patients with amiodarone pulmonary toxicity.
    Dake MD; Madison JM; Montgomery CK; Shellito JE; Hinchcliffe WA; Winkler ML; Bainton DF
    Am J Med; 1985 Mar; 78(3):506-12. PubMed ID: 2983550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and chemical assessment of thyroid function during therapy with amiodarone.
    Amico JA; Richardson V; Alpert B; Klein I
    Arch Intern Med; 1984 Mar; 144(3):487-90. PubMed ID: 6703817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Formation of multiple round foci in the lung during amiodarone therapy].
    Criée CP; Wilhelms E; Kneba M; Kreuzer H
    Dtsch Med Wochenschr; 1984 Mar; 109(13):499-500. PubMed ID: 6705699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug-induced phospholipidosis.
    Anderson N; Borlak J
    FEBS Lett; 2006 Oct; 580(23):5533-40. PubMed ID: 16979167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between in vitro phospholipidosis assay using HepG2 cells and 2-week toxicity studies in rats.
    Miyamoto S; Matsumoto A; Mori I; Horinouchi A
    Toxicol Mech Methods; 2009 Oct; 19(8):477-85. PubMed ID: 19793005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a novel set of biomarkers for evaluating phospholipidosis-inducing potential of compounds using rat liver microarray data measured 24-h after single dose administration.
    Yudate HT; Kai T; Aoki M; Minowa Y; Yamada T; Kimura T; Ono A; Yamada H; Ohno Y; Urushidani T
    Toxicology; 2012 May; 295(1-3):1-7. PubMed ID: 22426296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular biomarkers of phospholipidosis in rat blood and heart after amiodarone treatment.
    Bocchini N; Giantin M; Crivellente F; Ferraresso S; Faustinelli I; Dacasto M; Cristofori P
    J Appl Toxicol; 2015 Jan; 35(1):90-103. PubMed ID: 25580480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amiodarone hepatotoxicity.
    Elving LD; Hoefnagels WH; Van Haelst UJ; Griffioen G; Janssens AR; Ruiter DJ
    Neth J Med; 1986; 29(10):303-7. PubMed ID: 3796766
    [No Abstract]   [Full Text] [Related]  

  • 32. [Acute hepatopathy caused by amiodarone. Study of a case and review of the literature].
    Capron-Chivrac D; Reix N; Quénum C; Capron JP
    Gastroenterol Clin Biol; 1985; 9(6-7):535-9. PubMed ID: 4018488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversible, hepatic, lysosomal phospholipidosis in rat induced by subchronic daily administration of trospectomycin sulfate.
    Cox JW; Ulrich RG; Wynalda MA; McKenna R; Larsen ER; Ginsberg LC; Epps DE
    Biochem Pharmacol; 1989 Oct; 38(20):3535-41. PubMed ID: 2530987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug induced ocular lipoidosis.
    Clemett RS; MacKintosh HT
    Trans Ophthalmol Soc N Z; 1982; 34():52-8. PubMed ID: 6979822
    [No Abstract]   [Full Text] [Related]  

  • 35. Biomarkers to monitor drug-induced phospholipidosis.
    Baronas ET; Lee JW; Alden C; Hsieh FY
    Toxicol Appl Pharmacol; 2007 Jan; 218(1):72-8. PubMed ID: 17156806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic effects of amiodarone.
    Adams PC; Bennett MK; Holt DW
    Br J Clin Pract Suppl; 1986 Apr; 44():81-95. PubMed ID: 3089267
    [No Abstract]   [Full Text] [Related]  

  • 37. [Amiodaron neuropathy: drug-induced lipidosis (author's transl)].
    Dudognon P; Hauw JJ; de Baecque C; Escourolle R; Derrida JP; Nick J
    Nouv Presse Med; 1979 May; 8(21):1766-7. PubMed ID: 221884
    [No Abstract]   [Full Text] [Related]  

  • 38. Phenylacetylglycine, a putative biomarker of phospholipidosis: its origins and relevance to phospholipid accumulation using amiodarone treated rats as a model.
    Delaney J; Neville WA; Swain A; Miles A; Leonard MS; Waterfield CJ
    Biomarkers; 2004; 9(3):271-90. PubMed ID: 15764292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Neuropathy induced by amiodarone].
    Larre P; Coquet M; Maupetit J
    Nouv Presse Med; 1981 Sep; 10(33):2750. PubMed ID: 6270631
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparative evaluation of amiodarone-induced phospholipidosis and drug accumulation in Fischer-344 and Sprague-Dawley rats.
    Reasor MJ; McCloud CM; Beard TL; Ebert DC; Kacew S; Gardner MF; Aldern KA; Hostetler KY
    Toxicology; 1996 Jan; 106(1-3):139-47. PubMed ID: 8571385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.